These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28833361)

  • 1. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B.
    Hong X; Kim ES; Guo H
    Hepatology; 2017 Dec; 66(6):2066-2077. PubMed ID: 28833361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.
    Guo JT; Guo H
    Antiviral Res; 2015 Oct; 122():91-100. PubMed ID: 26272257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the study of hepatitis B virus covalently closed circular DNA.
    Ji M; Hu K
    Virol Sin; 2017 Dec; 32(6):454-464. PubMed ID: 29280054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
    Nassal M
    Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies for chronic hepatitis B.
    Bitton Alaluf M; Shlomai A
    Liver Int; 2016 Jun; 36(6):775-82. PubMed ID: 26854115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
    Guo Y; Li Y; Mu S; Zhang J; Yan Z
    J Med Virol; 2009 Jul; 81(7):1177-83. PubMed ID: 19475606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
    Singh P; Kairuz D; Arbuthnot P; Bloom K
    World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation in chronic hepatitis B virus infection.
    Dandri M
    Semin Immunopathol; 2020 Apr; 42(2):173-185. PubMed ID: 32185454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA.
    Yang HC; Chen PJ
    Virus Res; 2018 Jan; 244():304-310. PubMed ID: 28627393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
    Schreiner S; Nassal M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription.
    Yuan Y; Zhao K; Yao Y; Liu C; Chen Y; Li J; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Wu C; Chen X
    Antiviral Res; 2019 Dec; 172():104619. PubMed ID: 31600533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
    Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
    Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
    Revill P; Locarnini S
    Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status.
    Koumbi L; Pollicino T; Raimondo G; Stampoulis D; Khakoo S; Karayiannis P
    Virus Res; 2016 Jul; 220():150-60. PubMed ID: 27132039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
    Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
    Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
    Ohno M; Otsuka M; Kishikawa T; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jun; 21(23):7084-8. PubMed ID: 26109795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.